Board of Directors
White Fund’s board of directors is chaired by an independent director who specialises in the life sciences sector. The other directors and observers represent the fund shareholders.
White Fund’s board of directors makes investment and disinvestment decisions based on the proposals of the executive committee.
The board of directors meets 4 times per year or on an ad-hoc basis, as required.
MICHEL BAIJOT
Chairman of the board
PIERRE MERCENIER
Director
(OGEO FUND)
FRANCOIS FONTAINE
Director
(SFPI-FPIM)
GAETAN SERVAIS
Director
(Noshaq)
FILIP GOOSSENS
Senior Investment Manager
(PMV)
LAURENCE CARABIN
Observer
(CHU Liège)
MATHILDE LEVY
Observer
(Finance & Invest. Brussels)
MARC NOLET
Observer
CLAUDE MELEN
Observer (Solidaris)
Executive committee
The executive committee consists of four professionals from the investment and life sciences sectors. The executive committee analyses all investment opportunities and manages shareholdings.
ERIC BRANDT
LEEN LIMBOURG
PHILIPPE STAS
BENOIT FELLIN
Experts & support
The team at White Fund also includes experts from the medtech sector and a highly experienced legal, administrative and financial team. White Fund has also entered into a close partnership with Noshaq, which enables it to benefit from all the transversal skills that help it to function effectively.
